The Beauty Health Company $SKIN Shares Purchased by Mirabella Financial Services LLP

Mirabella Financial Services LLP raised its position in shares of The Beauty Health Company (NASDAQ:SKIN) by 5.0% during the 2nd quarter, Holdings Channel.com reports. The firm owned 12,861,549 shares of the company’s stock after acquiring an additional 614,602 shares during the period. Beauty Health accounts for 2.5% of Mirabella Financial Services LLP’s investment portfolio, making the stock its 5th biggest position. Mirabella Financial Services LLP owned 0.10% of Beauty Health worth $24,566,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of SKIN. Invesco Ltd. grew its stake in Beauty Health by 6.6% during the 2nd quarter. Invesco Ltd. now owns 98,427 shares of the company’s stock valued at $188,000 after acquiring an additional 6,059 shares in the last quarter. Rhumbline Advisers lifted its position in shares of Beauty Health by 28.6% in the second quarter. Rhumbline Advisers now owns 141,982 shares of the company’s stock worth $271,000 after purchasing an additional 31,565 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Beauty Health by 54.1% during the second quarter. JPMorgan Chase & Co. now owns 54,226 shares of the company’s stock worth $104,000 after purchasing an additional 19,032 shares during the period. Intech Investment Management LLC grew its position in Beauty Health by 55.4% during the second quarter. Intech Investment Management LLC now owns 70,573 shares of the company’s stock valued at $135,000 after purchasing an additional 25,156 shares in the last quarter. Finally, Police & Firemen s Retirement System of New Jersey increased its stake in Beauty Health by 87.5% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 31,408 shares of the company’s stock valued at $60,000 after buying an additional 14,653 shares during the period. 93.26% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have commented on SKIN shares. Weiss Ratings restated a “sell (d-)” rating on shares of Beauty Health in a research note on Friday, October 31st. Zacks Research downgraded shares of Beauty Health from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 19th. Cowen reaffirmed a “hold” rating on shares of Beauty Health in a research note on Monday, September 22nd. Roth Capital initiated coverage on Beauty Health in a report on Friday, September 19th. They set a “buy” rating and a $3.50 target price on the stock. Finally, Wall Street Zen cut Beauty Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. One investment analyst has rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $2.81.

Beauty Health Stock Down 0.6%

Beauty Health stock opened at $1.58 on Friday. The company has a debt-to-equity ratio of 5.53, a current ratio of 4.98 and a quick ratio of 4.07. The Beauty Health Company has a fifty-two week low of $0.78 and a fifty-two week high of $2.69. The firm has a fifty day moving average price of $1.47 and a two-hundred day moving average price of $1.76. The firm has a market cap of $201.45 million, a price-to-earnings ratio of -7.18 and a beta of 1.18.

Beauty Health (NASDAQ:SKIN) last posted its quarterly earnings data on Thursday, November 6th. The company reported ($0.09) EPS for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.01). Beauty Health had a negative return on equity of 19.70% and a negative net margin of 3.87%.The business had revenue of $70.66 million during the quarter, compared to the consensus estimate of $68.33 million. As a group, analysts forecast that The Beauty Health Company will post -0.25 earnings per share for the current year.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.